Conversion of 2-beta-D-ribofuranosylselenazole-4-carboxamide to an analogue of NAD with potent IMP dehydrogenase-inhibitory properties

Biochem Pharmacol. 1983 Sep 1;32(17):2633-6. doi: 10.1016/0006-2952(83)90038-2.
No abstract available

MeSH terms

  • Animals
  • Gas Chromatography-Mass Spectrometry
  • IMP Dehydrogenase / antagonists & inhibitors*
  • Ketone Oxidoreductases / antagonists & inhibitors*
  • Leukemia P388 / drug therapy*
  • Leukemia, Experimental / drug therapy*
  • Mice
  • NAD / analogs & derivatives*
  • Organoselenium Compounds*
  • Ribavirin* / analogs & derivatives
  • Ribavirin* / toxicity
  • Ribonucleosides* / chemical synthesis
  • Ribonucleosides* / toxicity*
  • Selenium / chemical synthesis
  • Selenium / toxicity*

Substances

  • Organoselenium Compounds
  • Ribonucleosides
  • NAD
  • Ribavirin
  • IMP Dehydrogenase
  • Ketone Oxidoreductases
  • Selenium
  • selenazofurin
  • tiazofurin